UroGen Pharma Ltd. (URGN): Expected earnings per share growth for next year

Corporate company logo of UroGen Pharma Ltd. (URGN)

UroGen Pharma Ltd. (URGN) demonstrates high macro resilience, as demand for oncology drugs remains independent of economic cycles. The company is implementing an innovative sustained-release drug delivery system to minimize surgical interventions. The current valuation of the company's EPS growth for the coming year clearly illustrates market expectations, where 777.60 serves as the final level mark. However, challenges with the commercialization of Jelmyto and regulatory barriers create risks for profitability.

UroGen (URGN): Expected earnings per share trend next year from 07/04/2022 to 11/17/2026

Summary analytical data breakdowns for UroGen Pharma (URGN)

- share price and consensus valuation forecast:
Fundamental company analysis:URGN, UroGen Pharma
Finished products of urogen.com

Analyzing expected earnings dynamics for the upcoming period is critical for selecting assets with a high margin of safety. This metric measures the speed at which institutional players revise their estimates, which in the case of UroGen Pharma Ltd. (URGN) reflects the risks of slow drug commercialization and pressure from insurers; therefore, the consensus estimate for net profit growth rates serves as an indicator of the business's resilience to market shocks.

Competing companies

ONC (BeiGene Ltd) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Therapeutics HALO|Net earnings per share growth forecast for next year Revolution Medicines, Inc. (RVMD)|Earnings growth forecast for next year Ascentage Pharma Group International (AAPG)|Earnings growth forecast for next year CGON (CG Oncology Inc)|Consensus forecast of earnings per share growth for next year Bicara Bio (BCAX)|PSNL - Net earnings per share growth forecast for next year|ERAS - Earnings growth forecast for next year|DCTH: Earnings growth forecast for next year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth forecast for next year|Expected earnings per share growth for next year AURA|Expected net earnings per share growth next year candeltx.com CADL|Earnings growth forecast for next year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year ACTU (Actuate Therapeutics Inc)|Expected earnings per share trend next year CTOR|tuhurabio.com - Earnings growth forecast for next year|Expected earnings per share trend next year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Net earnings per share growth forecast for next year|WHWK - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year tscan.com|CSBR: Expected earnings per share trend next year|Net earnings per share growth forecast for next year XBiotech USA (XBIT)|CVM: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year ostherapies.com OSTX|Projected earnings per share increase next year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth forecast for next year|ANL: Net earnings per share growth forecast for next year|VERU: Earnings growth forecast for next year|Net earnings per share change forecast for next year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year renovarobio.com RENB|Net earnings per share growth forecast for next year muraloncology.com (MURA)|Projected earnings per share increase next year KAPA|Earnings growth forecast for next year OKUR (onkuretherapeutics.com)|Projected earnings per share increase next year GDTC (CytoMed)|Curis - Earnings growth forecast for next year|APLM: Net earnings per share growth forecast for next year|Tharimmune (THAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth forecast for next year|Calidi Biotherapeutics (CLDI) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year SBFM|Net earnings per share growth forecast for next year XBIO (Xenetic Biosciences, Inc.)|Earnings growth forecast for next year SLRX (salariuspharma.com)|PPBT - Expected earnings per share growth for next year|AONC - Net earnings per share growth forecast for next year|Expected earnings per share trend next year BGNE (BeOne Medicines)|CKPT: Earnings growth forecast for next year|Elevation Oncology Inc. (ELEV) - Earnings growth forecast for next year|ICAD (iCAD) - Earnings growth forecast for next year|Earnings growth forecast for next year ikenaoncology.com|Earnings growth forecast for next year NTBL|Earnings growth forecast for next year Viracta Therapeutics Inc. (VIRX)|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year